Casdin Capital, LLC - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Casdin Capital, LLC held in its portfolio 38 assets valued at $1,609,916,188 (i.e. $1.61B).
The most valuable assets in the portfolio included: GENEDX HOLDINGS CORP ($391.11M), REVOLUTION MEDICINES INC ($205.29M), and BIOLIFE SOLUTIONS INC ($144.04M).
The chart below shows the top 10 valuable assets, and the table below shows the top 38 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
Casdin Capital, LLC - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| GENEDX HOLDINGS CORP | 3007164 | 391111750 | COM CL A |
| REVOLUTION MEDICINES INC | 2577333 | 205284573 | COM |
| BIOLIFE SOLUTIONS INC | 5957165 | 144044250 | COM NEW |
| STANDARD BIOTOOLS INC | 88783856 | 113643336 | COM |
| RELAY THERAPEUTICS INC | 13003574 | 110010236 | COM |
| STRUCTURE THERAPEUTICS INC | 1175000 | 81721250 | SPONSORED ADS |
| ILLUMINA INC | 600000 | 78696000 | COM |
| AVIDITY BIOSCIENCES INC | 1000000 | 72130000 | COM |
| BEAM THERAPEUTICS INC | 1600000 | 44352000 | COM |
| GUARDANT HEALTH INC | 380000 | 38813200 | COM |
| MAZE THERAPEUTICS INC | 758857 | 31439446 | COM |
| DENALI THERAPEUTICS INC | 1840000 | 30378400 | COM |
| ALNYLAM PHARMACEUTICALS INC | 75000 | 29823750 | COM |
| NEUROGENE INC | 1295361 | 26684437 | COM |
| 10X GENOMICS INC | 1400000 | 22834000 | CL A COM |
| ARS PHARMACEUTICALS INC | 1600000 | 18640000 | COM |
| TEMPUS AI INC | 294127 | 17368199 | CL A |
| UNITEDHEALTH GROUP INC | 50000 | 16505500 | COM |
| SEPTERNA INC | 553268 | 15425112 | COM |
| HIMS & HERS HEALTH INC | 385000 | 12500950 | COM CL A |
| VERACYTE INC | 276308 | 11632567 | COM |
| DEXCOM INC | 175000 | 11614750 | COM |
| SCHOLAR ROCK HLDG CORP | 260000 | 11453000 | COM |
| THE CIGNA GROUP | 40000 | 11009200 | COM |
| PRIME MEDICINE INC | 3167175 | 10990097 | COM |
| INCYTE CORP | 100000 | 9877000 | COM |
| QUEST DIAGNOSTICS INC | 50000 | 8676500 | COM |
| TAYSHA GENE THERAPIES INC | 1500000 | 8250000 | COM SHS |
| PACIFIC BIOSCIENCES CALIF IN | 4223767 | 7898444 | COM |
| LEGEND BIOTECH CORP | 215000 | 4674100 | SPONSORED ADS |
| BRIDGEBIO ONCOLOGY THERAPEUT | 282312 | 3534546 | COM NEW |
| ABSCI CORPORATION | 973260 | 3396677 | COM |
| CONTINEUM THERAPEUTICS INC | 148333 | 1695446 | CL A |
| MONTE ROSA THERAPEUTICS INC | 86014 | 1348700 | COM |
| CENTURY THERAPEUTICS INC | 1228190 | 1221803 | COM |
| RECURSION PHARMACEUTICALS IN | 165323 | 676171 | CL A |
| GINKGO BIOWORKS HOLDINGS INC | 36493 | 303257 | CL A NEW |
| TENAYA THERAPEUTICS INC | 361969 | 257541 | COM |